ScholarIQanswers from OpenAlex & ORCID
Per Eystein Lønning
ResearcherPublications, citations & collaboration network
Per Eystein Lønning is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Per Eystein Lønning have?
ScholarIQindexed works
Per Eystein Lønning has 637 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Per Eystein Lønning have?
ScholarIQcitation count
Per Eystein Lønning has 58,311 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Per Eystein Lønning?
ScholarIQh-index
Per Eystein Lønning has an h-index of 73 in OpenAlex.
What is the i10-index of Per Eystein Lønning?
ScholarIQi10-index
Per Eystein Lønning has an i10-index of 308 in OpenAlex.
What is the ORCID of Per Eystein Lønning?
ScholarIQorcid
The ORCID for Per Eystein Lønning is on the source record.
What is the OpenAlex record for Per Eystein Lønning?
ScholarIQopenalex
The OpenAlex for Per Eystein Lønning is on the source record.
What are the most-cited papers on Per Eystein Lønning?
ScholarIQmost cited works
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Thérese Sørlie, Charles M. Perou, Robert Tibshirani, Turid Aas, Stephanie Geisler, Hilde Johnsen, Trevor Hastie, Michael B. Eisen, Matt van de Rijn, Stefanie S. Jeffrey, Thor Thorsen, H. Quist, John C. Matese, Patrick O. Brown, David Botstein, Per Eystein Lønning, Anne‐Lise Børresen‐Dale
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
R. Charles Coombes, Emma Hall, Lorna J. Gibson, Robert Paridaens, Jacek Jassem, T. Delozier, Stephen E. Jones, Isabel Álvarez, Gianfilippo Bertelli, Olaf Ortmann, Alan S. Coates, Emilio Bajetta, David Dodwell, Robert E. Coleman, Lesley Fallowfield, E. Mickiewicz, Jørn Andersen, Per Eystein Lønning, Giorgio Cocconi, Alan L. Stewart, Nick Stuart, Claire Snowdon, M. Carpentieri, Giorgio Massimini, Judith M. Bliss
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R. Charles Coombes, Lucy Kilburn, CF Snowdon, Robert Paridaens, RE Coleman, SE Jones, Jacek Jassem, CJH van de Velde, T. Delozier, Isabel Álvarez, Lucia Del Mastro, Olaf Ortmann, K. Diedrich, AS Coates, Emilio Bajetta, Holmberg Sb, David Dodwell, E. Mickiewicz, J. Andersen, Per Eystein Lønning, Giorgio Cocconi, John Forbes, M. Castiglione, N Stuart, A. Stewart, Lesley Fallowfield, Gianfilippo Bertelli, Emma Hall, Richard Bogle, M. Carpentieri, E Colajori, Milayna Subar, Elizabeth Ireland, Judith M. Bliss
Genomic Evolution of Breast Cancer Metastasis and Relapse
Lucy Yates, Stian Knappskog, David C. Wedge, James H. R. Farmery, Santiago González, Iñigo Martincorena, Ludmil B. Alexandrov, Peter Van Loo, Hans Kristian Haugland, Peer Kaare Lilleng, Gunes Gundem, Moritz Gerstung, Elli Pappaemmanuil, Patrycja Gazińska, Shriram G. Bhosle, David Jones, Keiran Raine, Laura Mudie, Calli Latimer, Elinor J. Sawyer, Christine Desmedt, Christos Sotiriou, Michael R. Stratton, Anieta M. Sieuwerts, Andy G. Lynch, John W.M. Martens, Andrea L. Richardson, Andrew Tutt, Per Eystein Lønning, Peter J. Campbell
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer
Anna Bergamaschi, Young Ho Kim, Pei Wang, Thérese Sørlie, Tina Hernandez‐Boussard, Per Eystein Lønning, Robert Tibshirani, Anne‐Lise Børresen‐Dale, Jonathan R. Pollack